Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme

Clinical trial NCT00837824 · TERMINATED

Trial details

NCT number: NCT00837824
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Fabry Disease Chronic Kidney Disease, Stage IV (Severe)

Start date: 2002-12-01
Primary completion: 2003-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.